Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Patients With Schizophrenia

Keyphrases

• Patients with Schizophrenia 100%
• Soluble Urokinase Plasminogen Activator Receptor (suPAR) 100%
• Schizophrenia 42%
• Healthy Controls 28%
• Current Smoking 28%
• Cardiovascular Disease 14%
• Blood Samples 14%
• Inflammatory Activity 14%
• Aetiology of Schizophrenia 14%
• Type 2 Diabetes Mellitus (T2DM) 14%
• Increased Mortality 14%
• Male Sex 14%
• Pathophysiology of Schizophrenia 14%
• Psychiatric Symptoms 14%
• Low-grade Inflammation 14%
• Immune System 14%
• Diabetes Disease 14%
• Multiple Logistic Regression Model 14%
• Blood Donors 14%
• P-15 14%

Neuroscience

• Dementia Praecox 100%
• Urokinase Receptor 100%
• Etiology of Schizophrenia 12%

Nursing and Health Professions

• Urokinase Receptor 100%
• Pathophysiology 16%
• Non Insulin Dependent Diabetes Mellitus 16%
• Cardiovascular Disease 16%
• Inflammation 16%
• Multivariate Logistic Regression Analysis 16%
• Blood Donor 16%